{"id":26021,"date":"2025-09-27T10:00:00","date_gmt":"2025-09-27T08:00:00","guid":{"rendered":"https:\/\/www.physiotutors.com\/?p=26021"},"modified":"2025-10-28T13:37:06","modified_gmt":"2025-10-28T12:37:06","slug":"diagnostic-imaging-in-musculoskeletal-pain-guideline-adherence-and-clinical-realities","status":"publish","type":"post","link":"https:\/\/www.physiotutors.com\/diagnostic-imaging-in-musculoskeletal-pain-guideline-adherence-and-clinical-realities\/","title":{"rendered":"Diagnostic Imaging in Musculoskeletal Pain: Guideline Adherence and Clinical Realities"},"content":{"rendered":"\n

For physiotherapists working in primary care and musculoskeletal settings, the use of diagnostic imaging remains a complex and often controversial issue. While clinical guidelines offer a relatively unified stance, the realities of day-to-day practice introduce pressures, uncertainties, and system-level tensions that influence imaging decisions.<\/p>\n\n\n\n

This article explores the core principles of appropriate imaging use, the divergence from best-practice recommendations, and the clinical reasoning required to navigate these decisions effectively.<\/p>\n\n\n\n

The content of this post is largely based on Andrew Cuff’s work.<\/em><\/p>\n\n\n\n

Clinical Guidelines: When Should Imaging Be Used?<\/h2>\n\n\n\n

High-quality clinical guidelines, based on systematic evidence reviews, are unequivocal in their recommendations for non-traumatic MSK conditions. Imaging should be used only<\/strong> when:<\/p>\n\n\n\n

    \n
  1. There is suspicion of serious or specific pathology<\/strong>.
    <\/li>\n\n\n\n
  2. A patient has not responded to an adequate trial of conservative management<\/strong>.
    <\/li>\n\n\n\n
  3. The result is expected to alter clinical management<\/strong>.
    <\/li>\n<\/ol>\n\n\n\n

    These criteria aim to prevent unnecessary investigations and downstream effects that do not improve outcomes. Despite their clarity of these recommendations, implementation remains highly  inconsistent.<\/p>\n\n\n\n

    Rising Imaging Rates: A Global Trend<\/h2>\n\n\n\n

    Across healthcare systems, diagnostic imaging for MSK pain continues to rise. In the UK, for example, imaging rates increased approximately 20%<\/strong> between 2013 and the onset of the COVID-19 pandemic. Similar patterns are observed internationally, particularly in Australia and the United States.<\/p>\n\n\n\n

    A key driver post-pandemic has been the focus on a healthcare system \u201crecovery\u201d agenda. Targets to exceed pre-COVID imaging volumes (up to 120%) have been introduced, based on the assumption that increased rates of imaging equates to a better healthcare service. This idea unintentionally reinforces volume rather than appropriateness as a performance metric and creates a tension between policy and evidence-based care.<\/p>\n\n\n\n

    The fundamental question remains: Does increased imaging improve outcomes? Currently, the evidence indicates it does not. Despite higher imaging utilisation, pain-related disability, chronicity, and complexity remain unchanged.<\/p>\n\n\n\n

    The Key Question: Will Imaging Change What Happens Next?<\/h2>\n\n\n\n

    One of the most clinically relevant\u2014but frequently overlooked\u2014questions is:
    Will this imaging result change what I do?<\/p>\n\n\n

    \n
    \n\n \n \n \n \n \n <\/path>\n <\/g>\n <\/g>\n <\/g>\n <\/g>\n <\/svg>\n
    \n

    Will this imaging result change what I do?<\/p>\n <\/div>\n

    \n <\/div>\n <\/div>\n\n\n\n\n\n\n\n\n\n\n\n<\/div>\n\n\n\n

    In many cases, imaging is performed when patients fail to improve, but without a clear plan for what would follow based on the findings. Imaging in such scenarios serves more to manage clinician uncertainty or patient expectations than to support evidence-based decision-making.<\/p>\n\n\n\n

    Importantly, imaging should only be pursued if a meaningful therapeutic decision\u2014often involving an invasive intervention such as injection or surgery\u2014is both under consideration and<\/strong> acceptable to the patient. If not, the rationale for imaging becomes weak.<\/p>\n\n\n\n

    \"Guidelines<\/figure>\n\n\n\n

    Why Is There a Gap Between Guidelines and Practice?<\/h2>\n\n\n\n

    Several interlocking factors contribute to the persistent gap between what guidelines recommend and what clinicians do:<\/p>\n\n\n\n